Johnson & Johnson’s Covid-19 vaccine emergency use authorization revoked by FDA
The following is from Seeking Alpha.
Johnson & Johnson’s Covid-19 vaccine emergency use authorization revoked by FDA Read More »
Johnson and Johnson Covid-19 vaccine
(READ) FDA limits J&J Covid-19 vaccine due to blood clot risk
The following information is from the FDA re: its decision to limit use of J&J Covid-19 vaccine due to blood clot risk. Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to
(READ) FDA limits J&J Covid-19 vaccine due to blood clot risk Read More »
(READ) Study: AstraZeneca Covid-19 vaccine blood clot disorder far more common than reported
AstraZeneca Covid-19 is not approved in the U.S. A new study in Europe shows a concerning incidence of a serious brain blood clots, CVST, following AstraZeneca’s shot. Initially, the blood clots were thought to occur about 3 or 4 in
Experts: Women under age 50 should avoid Johnson and Johnson Covid-19 vaccine over concerns about blood clots
An editorial recently published in the Journal of the American Medical Association recommends women under age 50 avoid the Covid-19 vaccine made by Johnson and Johnson due to concerns about blood clots. The recommendation is accompanied by a description of
(READ) New blood disorder warnings appear on Covid-19 vaccine made by Johnson & Johnson
New blood disorder warnings appear on the Johnson and Johnson (Janssen) Covid-19 vaccine label, now that the federal “pause” on administering the vaccine has ended. The warnings flag an increased risk of thrombosis, clotting of the blood in the circulatory
(READ) New blood disorder warnings appear on Covid-19 vaccine made by Johnson & Johnson Read More »
